A big European study discovered that sex and psychiatric diagnosis interact in complicated ways, influencing cognitive ability, clinical characteristics, and health outcomes in persons with severe mental illness. The results, which will be published in Acta Psychiatrica Scandinavica in September 2025, have the potential to assist in modifying treatment methods for schizophrenia and bipolar illness. 

As part of the PsyCourse Study, researchers examined over 1,500 individuals with schizophrenia (SZ) or bipolar disorder (BD) from Germany and Austria. Individuals with BD outperformed those with SZ on measures of neurocognitive function and psychosocial functioning. 

Schizophrenia vs Bipolar Disorder: Cognitive Differences

Participants with schizophrenia reported more severe symptoms, poorer functioning, and overall worse cognitive test results. In contrast, people with bipolar illness performed better on activities that required verbal memory and psychomotor speed. 

The study emphasised the importance of sex in moderating the results. Female bipolar illness patients, for example, fared better on various cognitive tests than their male counterparts, notably in word memory and processing speed. 

However, substance use was heavily biassed towards men. Alcohol and cannabis usage was highest among men with schizophrenia, a trend associated with poor clinical outcomes and increased symptom loads. 

Interestingly, thyroid dysfunction was identified as a common comorbidity in both diagnostic categories. The researchers discovered that this syndrome, which can worsen mental symptoms, was consistently present regardless of gender. 

How Sex Influences Neurocognitive Outcomes

The findings indicate that broad treatment methods may overlook significant sex-based variations. "Our findings highlight the need for sex-sensitive strategies in clinical psychiatry," the paper's authors said. "Recognising these differences could improve cognitive rehabilitation and quality of life for people living with severe mental illness." 

Previous studies have found that schizophrenia and bipolar illness present overlapping but unique cognitive problems. This new study provides a thorough examination of how sex and diagnosis combine to influence outcomes in a large, clinically heterogeneous sample. 

Psychiatrists working in outpatient settings frequently confront the difficulty of balancing symptom control and long-term cognitive preservation. The findings indicate that males with schizophrenia may require stricter monitoring for drug use and its influence on cognition, whereas women with bipolar illnesses may benefit from specific cognitive training programs that capitalise on their respective capabilities. 

The data might potentially be used to improve patient education, promote early diagnosis of thyroid malfunction, and better integrate endocrinology into psychiatric therapy. 

The study's authors warn that cultural and socioeconomic issues, such as gender norms, stigma, and access to treatment, may also have an impact on results and should be investigated further. They recommend more research to investigate the molecular reasons behind the observed sex differences, such as hormonal impacts on brain function. 

Overall, the study underscores the importance of moving away from universal treatments in psychiatry. As knowledge increases, doctors and policymakers may discover new ways to create treatments that include not only diagnosis but also sex-specific requirements, possibly leading to more personalised and effective mental health care.